Makau Lee is a Gastroenterology physician. OpenAlex indexes 30 publications with 613 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2510 Lakeland Dr
Flowood, MS 392329513
Telephone
601-355-1234Provider last certified this registry record 28 Jul 2025.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
83.7%Proton pump inhibitor42.9%Omeprazole60%Pantoprazole Sodium30%Esomeprazole Magnesium6%Lansoprazole3%Part D<11 patientsOsmotic Laxative12.1%Gavilyte-C56%Peg-3350 And Electrolytes26%Gavilyte-G18%Part D≥55 patients+ 5 more classes in this area
Blood & clotting
10.7%Solutions for parenteral nutrition10.7%Peg 3350-Electrolyte100%Part D≥84 patientsAnti-infectives
5.6%Nucleoside and nucleotide reverse transcriptase inhibitors2.1%Vemlidy100%Part D<11 patientsNitroimidazole Antimicrobial1.9%Metronidazole100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1998–1998 per NIH RePORTER. The latest:
- ASPIRIN, NABUMETONE, AND COLONIC PROLIFERATION
University of Mississippi Medical Center
FY1998R01CA067847
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S3505 Chronic Tirzepatide Use Mimics Histology Findings of Celiac Disease: A Case Report
The American Journal of Gastroenterology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”